- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01028989
A Reduced Carbohydrate Diet Intervention for Polycystic Ovary Syndrome (PCOS)
A Reduced Carbohydrate Diet Intervention for PCOS
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Polycystic ovary syndrome (PCOS) is a heterogeneous syndrome affecting 5-10% of women of reproductive age. It is characterized by elevated circulating insulin, reduced insulin sensitivity, infertility, hyperandrogenism, and a multitude of symptoms that result in a decreased quality of life. The elevated insulin characteristic of PCOS is likely to play a major role in its pathogenesis by reducing insulin sensitivity and stimulating testosterone (T) production and increasing its free fraction. Although many women with PCOS are overweight/obese (10-50%), those who are non-obese suffer from the same symptoms as their obese counterparts. Thus, it is likely that the metabolic disturbances associated with PCOS predispose to weight gain, which in turn exacerbates PCOS by worsening insulin resistance. Manipulation of dietary carbohydrate quantity and quality (glycemic load; GL) may lower insulin and improve both reproductive and metabolic outcomes. No study has tested the efficacy of a lower GL diet among non-obese women with PCOS.
The Specific Aim of this proposal is to determine if a lower GL diet intervention is more effective than a standard (STD) diet in improving reproductive and metabolic outcomes of women with PCOS (both normal-weight and overweight/obese). We hypothesize that, in the absence of weight change, the lower GL diet will be more effective than the STD diet in decreasing insulin secretion, increasing insulin sensitivity, decreasing free T, decreasing fat from metabolically harmful sites, decreasing inflammation, and improving menstrual cyclicity and ovulation. Further, the lower GL diet will increase perceived fullness and decrease hunger, effects mediated via gut hormones.
Development of a diet that optimizes reproductive and metabolic health among women with PCOS will reduce reliance on pharmacologic treatments and improve quality of life, even in the absence of weight loss. This project is novel in being the first to conduct a highly controlled nutrition intervention in non-obese women with PCOS under weight stable conditions, utilizing robust measures of insulin secretion and action, fat distribution, inflammation, hunger/fullness, the gut hormone profile, and reproductive function. The results from this study can be used as a starting point from which to explore optimal diets for overweight women with PCOS.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- University of Alabama at Birmingham
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosed with PCOS
- Body mass index 18.5-35 kg/m2
Exclusion Criteria:
- Cushing's syndrome
- Type 1 or 2 diabetes
- Self-reported claustrophobia
- Androgenic tumors or adrenal hyperplasia
- Hyperprolactinemia
- Implanted metal items
- Use of metformin or other diabetes drug
- Women using oral contraceptives will not be excluded, but will be required to discontinue use of these agents 3 months prior to testing.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Reduced Glycemic Load Diet
36-40% fat; 40-42% carbohydrate; 18-22% protein Glycemic Load <=46 per 1000 calories |
36-40% fat; 40-42% carbohydrate; 18-22% protein Glycemic Load <=46 per 1000 calories |
|
Other: Standard Diet
25-27% fat; 55-57% carbohydrate; 18-22% protein Glycemic Load >=77 per 1000 calories |
25-27% fat; 55-57% carbohydrate; 18-22% protein Glycemic Load >=77 per 1000 calories |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Improving reproductive and metabolic outcomes of women with PCOS
Time Frame: 8 weeks
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The lower Glycemic Load diet will increase perceived fullness and decrease hunger, effects mediated via gut hormones.
Time Frame: 8 weeks
|
8 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Barbara A Gower, PhD, University of Alabama at Birmingham
- Principal Investigator: Fernando Ovalle, MD, University of Alabama at Birmingham
- Principal Investigator: G Wright Bates, MD, University of Alabama at Birmingham
Publications and helpful links
General Publications
- Gower BA, Goss AM. A lower-carbohydrate, higher-fat diet reduces abdominal and intermuscular fat and increases insulin sensitivity in adults at risk of type 2 diabetes. J Nutr. 2015 Jan;145(1):177S-83S. doi: 10.3945/jn.114.195065. Epub 2014 Dec 3.
- Douglas CC, Gower BA, Darnell BE, Ovalle F, Oster RA, Azziz R. Role of diet in the treatment of polycystic ovary syndrome. Fertil Steril. 2006 Mar;85(3):679-88. doi: 10.1016/j.fertnstert.2005.08.045.
- Hoover SE, Gower BA, Cedillo YE, Chandler-Laney PC, Deemer SE, Goss AM. Changes in Ghrelin and Glucagon following a Low Glycemic Load Diet in Women with PCOS. J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2151-e2161. doi: 10.1210/clinem/dgab028.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- F090407003
- 1R01HD054960-01A2 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Polycystic Ovary Syndrome
-
AnnieGuard Corp.Not yet recruitingPolycystic Ovary Syndrome | PCOS | Polycystic Ovary Syndrome (PCOS) | PCOS (Polycystic Ovary Syndrome)
-
Universitair Ziekenhuis BrusselNot yet recruiting
-
University Hospital, Strasbourg, FranceRecruitingPolycystic Ovary Syndrome (PCOS)France
-
Mst.Sumyara KhatunRecruitingPolycystic Ovary Syndrome (PCOS)Bangladesh
-
Ege UniversityRecruitingPolycystic Ovary Syndrome (PCOS)Turkey (Türkiye)
-
Al-Azhar UniversityCompletedPCOS (Polycystic Ovary Syndrome)Egypt
-
Shanghai Zhongshan HospitalRecruiting
-
Federal State Budgetary Institution, V. A. Almazov...Not yet recruitingPCOS (Polycystic Ovary Syndrome)
-
The Cleveland ClinicAmerican Academy of Family PhysiciansRecruitingPCOS (Polycystic Ovary Syndrome)United States
-
Shanghai First Maternity and Infant HospitalGengma People's HospitalRecruitingPCOS (Polycystic Ovary Syndrome)China
Clinical Trials on Reduced Glycemic Load Diet
-
Children's Hospital Medical Center, CincinnatiThrasher Research FundCompletedChildhood ObesityUnited States
-
Universidad Autonoma de Baja CaliforniaTerminated
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Rhode Island HospitalCystic Fibrosis FoundationRecruitingCystic Fibrosis | Cystic Fibrosis-related Diabetes | Cystic Fibrosis With Intestinal ManifestationsUnited States
-
Boston Children's HospitalCompletedCystic Fibrosis | Cystic Fibrosis-related Diabetes | Cystic Fibrosis With Intestinal ManifestationsUnited States
-
Boston Children's HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Charles...Completed
-
Queen's UniversityTerminatedObesity | Cardiovascular Disease | Metabolic SyndromeCanada
-
University of Arkansas, FayettevilleActive, not recruiting
-
Boston Children's HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Beth... and other collaboratorsCompleted
-
Ohio State UniversityRecruiting